Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6108973

COc1cc2c(CNC(C)=O)cnc(C(=O)c3cccc(OC(C)C)c3)c2cc1OC.O=C(O)C(F)(F)F

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GFPT1 Q06210 1/20 0.73
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.38
VNN1 O95497 2/20 0.38
DGAT2 Q96PD7 5/20 0.37
DPP4 P27487 1/20 0.37
PDGFRB P09619 1/20 0.37
FLT4 P35916 1/20 0.37
PDE10A Q9Y233 1/20 0.36
F3 P13726 1/20 0.36
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
KMT2A Q03164 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MTNR1A P48039 4/20 0.36
MTNR1B P49286 4/20 0.36
MET P08581 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6107805 0.95 GFPT1 (0.72) GFPT1GAAHPGDVNN1DGAT2
SCHEMBL6108765 0.90 GFPT1 (0.77) GFPT1GAAHPGDVNN1DGAT2
Trifluoroacetic Acid SCHEMBL6109077 0.89 GFPT1 (0.68) GFPT1GAAHPGDDGAT2PDGFRB
Trifluoroacetic Acid SCHEMBL6111475 0.89 GFPT1 (0.67) GFPT1GAAHPGDDGAT2MEN1
Trifluoroacetic Acid SCHEMBL6106759 0.88 GFPT1 (0.81) GFPT1VNN1DPP4PDGFRBFLT4
Trifluoroacetic Acid SCHEMBL5768365 0.88 GFPT1 (0.70) GFPT1VNN1DPP4PDE10AF3
Trifluoroacetic Acid SCHEMBL6108469 0.88 GFPT1 (0.70) GFPT1DPP4
Trifluoroacetic Acid SCHEMBL5763517 0.87 GFPT1 (0.95) GFPT1GAAVNN1DPP4PDGFRB
Trifluoroacetic Acid SCHEMBL6108786 0.86 GFPT1 (0.64) GFPT1HPGDDGAT2MEN1LMNA
Trifluoroacetic Acid SCHEMBL5744667 0.86 GFPT1 (0.68) GFPT1DPP4PDE10AF3MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7067529-B2 Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors HOFFMANN-LA ROCHE INC. (US) 2006-06-27 US disclosed
US-20040259910-A1 Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors BOLIN DAVID ROBERT (US) 2004-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259910-A1 Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors GFPT1, GLS2, GLS GFPT1 1/4885GAA 84/4885HPGD 892/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.